Radiomics and Imaging Innovations in Cancer Detection

Radiomics involves extracting large amounts of quantitative data from medical images using artificial intelligence and machine learning. This approach reveals patterns not visible to the human eye and aids in cancer detection, characterization, and treatment response prediction. Innovations in imaging technologies, including functional MRI, PET-CT, and contrast-enhanced techniques, enhance tumor visualization and staging accuracy. Radiomics holds promise for non-invasive, personalized oncology by linking imaging features with molecular and clinical data. It can guide biopsy decisions, monitor disease progression, and optimize therapy selection. Integrating radiomics into clinical workflows may transform cancer diagnosis and management.

    Related Conference of Radiomics and Imaging Innovations in Cancer Detection

    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    March 30-31, 2026

    26th World Congress on Cancer and Diagnostics

    London, UK
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 23-24, 2026

    27th World Congress on Cancer Summit

    Paris, France
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France

    Radiomics and Imaging Innovations in Cancer Detection Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in